FIELD: chemistry.
SUBSTANCE: present invention relates to diarylhydantoins, namely to a compound of formula
.
EFFECT: disclosed compound has high antagonist activity with minimum agonist activity with respect to androgen receptors (AR) and inhibits the development of hormone-resistant prostate cancer.
8 cl, 41 dwg, 11 tbl, 61 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIARYL HYDANTOINS | 2011 |
|
RU2638833C2 |
| DIARYL-SPIROHYDANTOIC COMPOUNDS USEFUL IN HYPERPOLIFERATIVE DISORDER TREATMENT | 2012 |
|
RU2668972C2 |
| DIARYLTHIOHYDATOIC COMPOUNDS | 2007 |
|
RU2449993C2 |
| METHODS OF FORMING GLYCOSIDE BONDS, CHEMICAL COMPOSITION, GLYCOSIDE AND GLYCOSIDE LIBRARY | 1994 |
|
RU2134693C1 |
| COMPOUNDS USEFUL AS TRPM8 MODULATORS | 2011 |
|
RU2608109C2 |
| VITAMIN D ANALOGS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2153491C2 |
| METHOD FOR REDUCING OF BROKEN OPYOID RECEPTOR FUNCTIONS | 1996 |
|
RU2307833C2 |
| BENZO-DERIVATIVES WITH SIX-MEMBERED RING AS DPP-4 INHIBITOR AND USE THEREOF | 2015 |
|
RU2702644C2 |
| DERIVATIVES OF PIPERAZINE AND PIPERIDINE AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2194702C2 |
| PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
